Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.
<h4>Objective</h4>The objective was to determine the safety of ocrelizumab (OCR) in patients with rheumatoid arthritis (RA).<h4>Methods</h4>This was an analysis of the double-blind, placebo-controlled periods and long-term follow-up of 4 OCR phase III trials in RA (SCRIPT, ST...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/49652c7e07ca420993dde7e84ab236dd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!